Q-Avail™ 100 mg 60 gels

Study results show peak absorption of Q-Avail™ is 8 times greater than dry powder and two times greater than its toughest competition when compared to dry powder, liposomal, nanoparticle, and partial dissolved in oil formulations. Q-Avail™ underwent other clinical trials as well including a 36-hour peak absorption study to determine the total amount of CoQ10 absorbed and a 28-day steady state study to determine the amount of CoQ10 in the blood plasma available for use by the body cells. In these studies, Q-Avail™ was compared to a standard dry powder CoQ10 product. The results of the 36-hour absorption study showed that Q-Avail™ had a total absorption of 11.65% compared to dry powder having an absorption of 1.32%, which makes Q-Avail ™ 783% more absorbable than dry powder. The results of the 28-day steady state study showed that at the end of 28 days there were 8989 ug/ml of Q-Avail™ available for use by the cells, compared to 1623 ug/ml of dry powder CoQ10. This makes Q-Avail™ 441% more bioavailable than dry powder CoQ10. Q•Avail™ is designed for optimal absorption, stability and cost-efficiency. Oral supplementation with CoQ10 is often desired to improve immune function, mitochondrial metabolism and energy production in the support of fatigue-related disorders, the enhancement of athletic performance, periodontal problems and the support of cardiomyopathy and neurodegenerative conditions such as Parkinson’s. CoQ10 has also been demonstrated to be an effective antioxidant, reducing lipid peroxidation.